Pharmacokinetics and pharmacodynamics of the novel PAR-1 antagonist vorapaxar in patients with end-stage renal disease

被引：0
作者：
Teddy Kosoglou
Walter K. Kraft
Bharath Kumar
Paul Statkevich
Fengjuan Xuan
Lei Ma
Lisa K. Jennings
James E. Schiller
Ronald B. Langdon
David L. Cutler
机构：
[1] Merck Sharp & Dohme Corp.,Department of Pharmacology and Experimental Therapeutics
[2] Thomas Jefferson University,Clinical Pharmacology, Merck Research Laboratories
[3] University of Tennessee Health Science Center,undefined
[4] Merck Sharp & Dohme Corp.,undefined
来源：
European Journal of Clinical Pharmacology | 2012年 / 68卷
关键词：
Vorapaxar; SCH 530348; PAR-1; Renal disease; Pharmacokinetics; Pharmacodynamics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1049 / 1056
页数：7
相关论文
共 50 条
[21]   PHARMACOKINETICS AND PHARMACODYNAMICS OF THE 3 ISOMERS OF MIVACURIUM IN HEALTH, IN END-STAGE RENAL-FAILURE AND IN PATIENTS WITH IMPAIRED RENAL-FUNCTION [J].
HEADRAPSON, AG ;
DEVLIN, JC ;
PARKER, CJR ;
HUNTER, JM .
BRITISH JOURNAL OF ANAESTHESIA, 1995, 75 (01) :31-36
[22]   Safety and pharmacokinetics of agalsidase alfa in patients with Fabry disease and end-stage renal disease [J].
Pastores, Gregory M. ;
Boyd, Ellen ;
Crandall, Kerry ;
Whelan, Alison ;
Piersall, Linda ;
Barnett, Natalie .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (07) :1920-1925
[23]   THE EFFECT OF HEMODIALYSIS ON THE PHARMACOKINETICS OF TENOXICAM IN PATIENTS WITH END-STAGE RENAL-DISEASE [J].
ALGHAMDI, MS ;
ALMOHANNA, FA ;
ALMUSTAFA, ZH ;
ALSAEED, IS .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (02) :197-199
[24]   Alteration of thiamine pharmacokinetics by end-stage renal disease (ESRD) [J].
Frank, T ;
Bitsch, R ;
Maiwald, J ;
Stein, G .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1999, 37 (09) :449-455
[25]   Pharmacokinetics of trabectedin on hemodialysis: an application for the management of cancer patients with end-stage renal disease [J].
Juliette Thariat ;
Marie-Christine Etienne-Grimaldi ;
Vincent Launay-Vacher ;
Arturo Soto-Matos ;
Carlos Fernandez-Teruel ;
Thomas Ghafari ;
Pierre-Yves Marcy ;
Gérard Milano ;
Nicole Renée ;
Lauris Gastaud ;
Antoine Thyss .
Cancer Chemotherapy and Pharmacology, 2011, 68 :1363-1367
[26]   Pharmacokinetics of trabectedin on hemodialysis: an application for the management of cancer patients with end-stage renal disease [J].
Thariat, Juliette ;
Etienne-Grimaldi, Marie-Christine ;
Launay-Vacher, Vincent ;
Soto-Matos, Arturo ;
Fernandez-Teruel, Carlos ;
Ghafari, Thomas ;
Marcy, Pierre-Yves ;
Milano, Gerard ;
Renee, Nicole ;
Gastaud, Lauris ;
Thyss, Antoine .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (05) :1363-1367
[27]   BIOAVAILABILITY OF LABETALOL IN PATIENTS WITH END-STAGE RENAL-DISEASE [J].
LUKE, DR ;
AWNI, WM ;
HALSTENSON, CE ;
OPSAHL, JA ;
MATZKE, GR .
THERAPEUTIC DRUG MONITORING, 1992, 14 (03) :203-208
[28]   Pharmacokinetics of topiramate in patients with renal impairment, end-stage renal disease undergoing hemodialysis, or hepatic impairment [J].
Manitpisitkul, Prasarn ;
Curtin, Christopher R. ;
Shalayda, Kevin ;
Wang, Shean-Sheng ;
Ford, Lisa ;
Heald, Donald L. .
EPILEPSY RESEARCH, 2014, 108 (05) :891-901
[29]   Pharmacokinetics of Tofacitinib, a Janus Kinase Inhibitor, in Patients With Impaired Renal Function and End-Stage Renal Disease [J].
Krishnaswami, Sriram ;
Chow, Vincent ;
Boy, Mary ;
Wang, Cunshan ;
Chan, Gary .
JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (01) :46-52
[30]   Effect of peritoneal dialysis in end-stage renal disease on apixaban pharmacokinetics [J].
Peyro-Saint-Paul, Laure ;
Bechade, Clemence ;
Cesbron, Alexandre ;
Debruyne, Daniele ;
Brionne, Marie ;
Brucato, Sylvie ;
Hanoy, Melanie ;
Dumont, Audrey ;
Briant, Anais R. ;
Parienti, Jean-Jacques ;
Lobbedez, Thierry ;
Ficheux, Maxence .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 (08) :1918-1920
12345